Clinical trial

Expanded Access to ANG1005 for Individual Patients

NCT02755987

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Study timeline

Registry last updated2016-06-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Anaplastic Astrocytomaunresolved

Anaplastic Oligodendrogliomaunresolved

Breast Cancer With Recurrent Brain Metastasesunresolved

Leptomeningeal Carcinomatosisunresolved

Interventions

ANG1005DRUG

Sponsors & collaborators

Angiochem Inclead sponsor

Mapped research locations

San AntonioTexas, United States1 OrangeCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02755987 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.